During the past decade, Southern Urogynecology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Urogynecology" #1 sponsor was "Axonics Modulation Technologies, Inc." with 1 trials, followed by "BTL Industries Ltd." with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "MedtronicNeuro" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Southern Urogynecology" are "Overactive Bladder" (3 trials), "Urinary Urge Incontinence" (2 trials), "Fecal Incontinence" (1 trials), "Pelvic Organ Prolapse" (1 trials) and "Urgency-Frequency" (1 trials). Many other conditions were trialed in "Southern Urogynecology" in a lesser frequency.

Most popular intervention types in "Southern Urogynecology" are "Device" (2 trials), "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fesoterodine 4mg" (1 trials), "Fesoterodine 8mg" (1 trials), "InterStim Basic Evaluation lead and foramen needle" (1 trials), "Placebo" (1 trials) and "Prolapse Repair" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Urogynecology" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Southern Urogynecology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Southern Urogynecology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southern Urogynecology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".